Last reviewed · How we verify
NCT05427058
Hypogastric Plexus Block and Ganglion Impar Block for Cervical and Endometrial Cancer Pain Management
NA trial testing Superior Hypogastric Plexus Block in Cervical Cancer in 36 participants. Currently enrolling.
30 September 2025
Quick facts
| Lead sponsor | University of Brawijaya |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | supportive care |
| Enrollment | 36 |
| Start date | 23 July 2024 |
| Primary completion | 30 September 2025 |
| Estimated completion | 30 January 2026 |
| Sites | 1 location across Indonesia |
Drugs / interventions tested
- Superior Hypogastric Plexus Block
- Ganglion Impar Block
Conditions studied
- Cervical Cancer — all drugs for Cervical Cancer →
- Endometrial Cancer — all drugs for Endometrial Cancer →
Sponsor
University of Brawijaya
Who can join
18 and older, female only, with Cervical Cancer or Endometrial Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study compared the efficacy and safety of superior hypogastric plexus block and ganglion impar block procedures on the management of pelvic and perineal cancer pain in patients with cervical and endometrial cancer
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05427058
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cervical Cancer
Currently open trials in the same condition.
- NCT07276360 — Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda · Phase 2 · recruiting
- NCT05570422 — A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy of KRC-01 · Phase 1 · recruiting
- NCT07225530 — Implementation of Screen, Treat, and Triage for Women Living With HIV in La Romana (iSTAR) · NA · recruiting
- NCT07209917 — Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India · NA · recruiting
- NCT07256236 — SKB264 Plus QL1706 in Recurrent or Metastatic Cervical Cancer · Phase 2 · recruiting
Other University of Brawijaya trials
Trials by the same sponsor.
- NCT07031726 — Effect of Nutrition and Wellness Program on Health Parameter Among Employees · NA · completed
- NCT07316400 — PsP Ganoderma Lucidum Supplementation and Biomarker Changes in Smokers · NA · completed
- NCT06355115 — Prophylactic Antibiotics Duration Towards Healing and Risk of Infection in Permanent Pacemaker (PPM) Installation · Phase 2 · recruiting
- NCT06426537 — Colchicine's Efficacy in MI Patients: Comparing PCI and Non-Reperfusion Approaches · EARLY_PHASE1 · completed
- NCT05740878 — Administration of ONS Based on Purple Sweet Potato in Head and Neck Cancer Patients With Radiotherapy · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05427058 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Brawijaya
- Last refreshed: 10 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05427058.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing